About Event
This Was The Only Industry-Focused Forum to Advance Novel Inflammasome Therapeutics Across Diseases to Patients in Need
In amidst of the fields anticipation for clinical study results, the ever-present industry challenges remained and it was the time for biopharmas focusing on targeting the inflammasome to double down on these challenges.
With that, lied a unique opportunity to confront these hurdles head-on, for the past 6 years, the Inflammasome Therapeutics Summit has consistently provided a vital forum for dedicated professionals to share knowledge, uncover creative solutions and work together to tackle those ever-present challenges from effective preclinical models to biomarkers and even clinical endpoints, and the 6th Inflammasome Therapeutics Summit returned for 2024 to do exactly that.
Why Did The Attendees Prioritize The Inflammasome Therapeutics Summit?
100+ Attendees from across the global inflammasome landscape
25+ Expert Speakers with diverse and insightful presentations
6+ hours of face-to-face networking to build new connections
60+ Leading
organizations in
attendance for you
to meet
3 Interactive
discussion-led preconference
workshops
Who Did The Attendees Meet in 2024?
This September, 100+ decision makers representing the leading Inflammasome biopharma companies gathered together along with the industry’s foremost thought leading academics.
This inclusive gathering united individuals from across the drug development cycle including discovery, biology, preclinical research, translational and clinical, all united in a collective effort to advance inflammasome therapeutics to the patients who need them most.
What Your Peers Said:
